Who has invested in Purespring Therapeutics?

Sofinnova Partners, Gilde Healthcare, Forbion, British Patient Capital, Syncona are named among the investors backing Purespring Therapeutics.

Purespring Therapeutics Funding: $105M Raised, Series B

Purespring Therapeutics funding overview

Purespring Therapeutics is a Biotech company based in London, United Kingdom. Purespring Therapeutics has raised $105M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in October 2024. The round record for Purespring Therapeutics runs through 2024; nothing later has been disclosed. Investors on record include Sofinnova Partners, Gilde Healthcare, Forbion, British Patient Capital, Syncona. 5 distinct backers are named across the disclosed rounds.

Purespring Therapeutics at a glance

Total raised: $105M
Latest round: Series B
Latest round date: October 2024
Industry: Biotech
Headquarters: London, United Kingdom
Notable investors: Sofinnova Partners, Gilde Healthcare, Forbion, British Patient Capital, Syncona

Frequently asked about Purespring Therapeutics funding

How much has Purespring Therapeutics raised?: Purespring Therapeutics has raised $105M in total disclosed funding across the rounds on record.
Who has invested in Purespring Therapeutics?: Sofinnova Partners, Gilde Healthcare, Forbion, British Patient Capital, Syncona are named among the investors backing Purespring Therapeutics.
What was the latest Purespring Therapeutics funding round?: The most recent disclosed round is a Series B, announced in October 2024.
Where is Purespring Therapeutics based?: Purespring Therapeutics is based in London, United Kingdom.
What sector does Purespring Therapeutics operate in?: Purespring Therapeutics is tracked under Biotech from London, United Kingdom, with $105M in disclosed funding.
When did Purespring Therapeutics last raise?: The last disclosed Purespring Therapeutics round closed in October 2024 at Series B.

Purespring Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Biotech companies in London below to benchmark round size and investor mix.

Purespring Therapeutics Funding: $105M Raised, Series B

Purespring Therapeutics funding overview

Purespring Therapeutics at a glance

Frequently asked about Purespring Therapeutics funding

Companies related to Purespring Therapeutics (40)

Browse related funding lists (10)